
The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …

Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …

An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …

Merck & Co and Reckitt Benckiser have collectively been fined millions of euros by French authorities over their role in …

Merck has announced it is working with digital health specialist Ayogo to develop a new game aimed at helping type …

UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …

A packaging plant in Ireland is the latest to come into the cross-hairs of the people at Pfizer tasked with …

Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …

GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …

Merck has posted impressive results for its new melanoma vaccine MK-3475 as it looks to vie for a place in …

Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …


Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …